Monkeypox Spreads in West, Baffling African Scientists
Scientists who have monitored numerous outbreaks of monkeypox in Africa say they are baffled by the disease’s recent spread in Europe and North America. Cases of the smallpox-related disease have previously been seen only among people with links to central and West Africa. But in the past week, Britain, Spain, Portugal, Italy, U.S., Sweden and Canada all reported infections, mostly in young men who hadn’t previously traveled to Africa. France, Germany, Belgium and Australia confirmed their first cases of monkeypox on Friday. “I’m stunned by this. Every day I wake up and there are more countries infe...
Source: TIME: Health - May 20, 2022 Category: Consumer Health News Authors: Maria Cheng / AP Tags: Uncategorized Africa Disease healthscienceclimate wire Source Type: news

Janssen Discontinues Collaboration and License Agreements with Bavarian Nordic in Hepatitis B and Human Papillomavirus
NEW BRUNSWICK, NJ, May 9, 2022 - The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the termination of its collaboration and license agreements with Bavarian Nordic that leverage Bavarian Nordic’s MVA-BN® (Modified Vaccinia Ankara - Bavarian Nordic) technology to develop potential vaccines against the hepatitis B virus and human papillomaviruses. Janssen remains committed to its strong collaboration with Bavarian Nordic in the quest to prevent and cure infectious diseases – with collaborations in HIV and Ebola still ongoing.No clinical studies in hepatitis B have been initiated by Janssen ut...
Source: Johnson and Johnson - May 9, 2022 Category: Pharmaceuticals Source Type: news

Congo-Kinshasa: Ebola Vaccination Campaign Begins to Counter New Outbreak
[UN News] An Ebola vaccination campaign has begun in northwest Democratic Republic of the Congo (DRC), to halt the spread of a deadly new outbreak in the country, where the disease is endemic. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 28, 2022 Category: African Health Source Type: news

Democratic Republic of the Congo launches vaccine campaign amid deadly Ebola outbreak
As the Democratic Republic of the Congo battles its 14th Ebola outbreak since 1976, the World Health Organization announced Wednesday a vaccination campaign in the Central African country to halt the spread. (Source: Health News - UPI.com)
Source: Health News - UPI.com - April 27, 2022 Category: Consumer Health News Source Type: news

Ebola vaccination campaign begins in DR Congo to counter new outbreak
An Ebola vaccination campaign has begun in northwest Democratic Republic of the Congo (DRC), to halt the spread of a deadly new outbreak in the country, where the disease is endemic. (Source: UN News Centre - Health, Poverty, Food Security)
Source: UN News Centre - Health, Poverty, Food Security - April 27, 2022 Category: International Medicine & Public Health Source Type: news

Johnson & Johnson Launches Next Satellite Center for Global Health Discovery at Holistic Drug Discovery and Development Centre, University of Cape Town, Focused on Antimicrobial Resistance (AMR)
Cape Town, South Africa, April 25, 2022 – Johnson & Johnson (the Company) today announced the launch of the J&J Satellite Center for Global Health Discovery (Satellite Center) at the Holistic Drug Discovery and Development (H3D) Centre, University of Cape Town, in Cape Town, South Africa. This marks the latest expansion of the J&J Centers for Global Health Discovery (J&J Centers), a global network of research collaborations between the Company and leading research institutions to accelerate translational and discovery research to address some of the world’s most pressing global health challenges. The Sa...
Source: Johnson and Johnson - April 25, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news

Drugged Water: A New Global Pandemic Hiding in Plain Sight?
Credit: WHOBy Baher KamalMADRID, Apr 13 2022 (IPS) People around the world are unknowingly being exposed to water laced with antibiotics, which could spark the rise of drug-resistant pathogens and potentially fuel another global pandemic, warns a new report. The study, elaborated by the United Nations Environment Programme (UNEP), found that, globally, not enough attention is being focused on the threat posed by antimicrobial resistance with most antibiotics being excreted into the environment via toilets or through open defecation. Already in 2015, 34.8 billion daily doses of antibiotics were consumed, with up to 90 perce...
Source: IPS Inter Press Service - Health - April 13, 2022 Category: International Medicine & Public Health Authors: Baher Kamal Tags: Development & Aid Environment Global Headlines Health TerraViva United Nations Water & Sanitation Source Type: news

Would YOU volunteer to test a vaccine for Ebola? Dental nurse was the first in the world to have it
Dental nurse Caroline Heath readily admits she'd never have considered taking part in a trial for a vaccine against the deadly Ebola virus if she hadn't happened to be at a talk about coronavirus. (Source: the Mail online | Health)
Source: the Mail online | Health - April 11, 2022 Category: Consumer Health News Source Type: news

‘Africa must be self-sufficient’: John Nkengasong on learning the deadly lessons of pandemics
The outgoing director of Africa Centres for Disease Control has seen Ebola, Aids and now Covid – and warns complacency is dangerousThe past five years have been “like going from one fire to the next, with barely any time to catch your breath”, says John Nkengasong, the outgoing head of the body charged with responding to health emergencies in Africa.A relentless term as the first director of the Africa Centres for Disease Control and Prevention (Africa CDC) saw Nkengasong manage the response to Ebola and Lassa fever outbreaks. But nothing compared to the formidable test brought by Covid-19.Continue reading... (Source...
Source: Guardian Unlimited Science - March 28, 2022 Category: Science Authors: Emmanuel Akinwotu Tags: Global development Global health Africa Coronavirus Infectious diseases World news Science Microbiology Aids and HIV Vaccines and immunisation Ebola Inequality Source Type: news

Professor Sarah Gilbert on the legacy of lockdown: We must ensure we are better prepared for future outbreaks
The pandemic has taught us that viruses are not easy to identify – and can spread like wildfireAs we move into the late stages of the pandemic, it is important to reflect on the scientific discoveries of the past two years, so that we are better prepared for future virus outbreaks. I believe there are two areas in particular where we can learn from the experience.The first is understanding that outbreaks are not always easy to identify quickly. Viruses such as Nipah and Ebola cause severe, and therefore obvious, illness in everyone who is infected. The fatality rate is high but transmissibility is low, with an R number ...
Source: Guardian Unlimited Science - March 18, 2022 Category: Science Authors: Prof Sarah Gilbert Tags: Coronavirus Infectious diseases Medical research Science Microbiology Vaccines and immunisation Health Society AstraZeneca Source Type: news

Moderna Is Sharing Its Vaccine Technology With Low-Income Countries. But That Doesn ’t Mean Locally Produced Shots Are Coming Soon
Moderna, the Massachusetts-based company behind one of the two mRNA COVID-19 vaccines, made the decision in 2020 not to enforce the patent on its shot. The move was meant to encourage low- and middle-income countries that couldn’t afford to purchase billions of doses of the vaccine (as the U.S., Canada, and many European countries had done) to develop their own versions of the shot using less expensive resources. On Mar. 8, Moderna went a step further, saying that it will now extend that promise indefinitely in the 92 low- and middle-income countries that are receiving doses from COVAX, the global vaccine distributio...
Source: TIME: Health - March 9, 2022 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news

Use of Ebola Vaccine: Expansion of Recommendations of the Advisory Committee on Immunization Practices To Include Two Additional Populations - United States, 2021
This report describes updated guidance on use of the Ebola vaccine. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - February 24, 2022 Category: American Health Tags: Advisory Committee on Immunization Practices (ACIP) Diseases & Conditions Ebola Virus Disease Global Health Healthy Living MMWR Morbidity Mortality Weekly Report Travel Health Vaccination Vaccines Source Type: news

The Omicron Wave Is Receding But the Pandemic Is Far From Over
The U.S. has experienced a brutal winter wave of COVID-19, driven by the highly transmissible Omicron variant. Daily deaths are higher today than they were during the peak of last fall’s Delta wave, and have plateaued at about 2,500 per day. Many hospitals are still under huge strain and are postponing elective surgeries to free up beds for patients with COVID-19. Daily cases have been higher than during the Delta surge, despite multiple eager predictions in the past that we had reached herd immunity and that the pandemic was over. Nevertheless, there are promising signs that we are turning a corner. New daily cases ...
Source: TIME: Health - February 15, 2022 Category: Consumer Health News Authors: Gavin Yamey, Abraar Karan and Ranu Dhillon Tags: Uncategorized COVID-19 Source Type: news

Congo-Kinshasa: Lessons From the DRC's 10th Ebola Epidemic - the People May Know Best
[The Conversation Africa] The tenth Ebola epidemic in the Democratic Republic of the Congo (DRC) was declared in North Kivu on 1 August 2018. The international response to the epidemic was significant. More than half a billion dollars of international aid flowed into the country. A newly approved, highly protective vaccine was used, and new medicines were tested and found to reduce mortality. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 13, 2022 Category: African Health Source Type: news

Ebola vaccine being used in Congo produces lasting antibody response, study finds
FINDINGSA new study by UCLA researchers and colleagues demonstrates that the Ebola vaccine known as rVSV ΔG-ZEBOV-GP results in a robust and enduring antibody response among vaccinated individuals in areas of the Democratic Republic of Congo that are experiencing outbreaks of the disease. Among the more than 600 study participants, 95.6% demonstrated antibody persistence six months after they received the vaccine.The study is the first published research examining post –Ebola-vaccination antibody response in the DRC, a nation of nearly 90 million. While long-term analyses of the study cohort continue, the findings will ...
Source: UCLA Newsroom: Health Sciences - February 8, 2022 Category: Universities & Medical Training Source Type: news